MFSD8 and neuronal ceroid lipofuscinosis 7: Here, we tested the feasibility and efficacy of an AAV9-based strategy to deliver the codon-optimized human MFSD8 gene in fibroblasts from a CLN7 patient in vitro as well as in a CLN7 mouse model to investigate whether this would predict a benefit to pediatric patients with CLN7 disease.